Immunoassay Methods and their Applications in Pharmaceutical Analysis: Basic Methodology and Recent Advances

Abstract

Immunoassays are bioanalytical methods in which the quantitation of the analyte depends on the reaction of an antigen (analyte) and an antibody. Immunoassays have been widely used in many important areas of pharmaceutical analysis such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetic and bioequivalence studies in drug discovery and pharmaceutical industries. The importance and widespread of immunoassay methods in pharmaceutical analysis are attributed to their inherent specificity, high-throughput, and high sensitivity for the analysis of wide range of analytes in biological samples. Recently, marked improvements were achieved in the field of immunoassay development for the purposes of pharmaceutical analysis. These improvements involved the preparation of the unique immunoanalytical reagents, analysis of new categories of compounds, methodology, and instrumentation. The basic methodologies and recent advances in immunoassay methods applied in different fields of pharmaceutical analysis have been reviewed.

Analytical techniques for screening of cannabis and derivatives from human hair specimens

“…However, the drawback was the probability of this method to cause denaturation of antibodies used in the immunoassay. 66…”

Tumor biomarkers for diagnosis, prognosis and targeted therapy

“…62 – 64 In addition, RIA is advantageous in measuring a variety of immunoreactive substances for its high sensitivity, and specificity. 65 , 66 For example, RIA is utilized in the detection of early-stage tumors, and is an effective method in combination with clinical pathological assay to provide comprehensive evaluations of tumors. 67 However, the shortcomings of RIA are also prominent, such as isotope contamination due to the radioactive wastes, the requirement of specific safety equipment, and the excessive radiation exposure of workers induced by the long incubation time.…”

Advancements in Cortisol Detection: From Conventional Methods to Next-Generation Technologies for Enhanced Hormone Monitoring

“…Monoclonal antibody-based immunoassays are ubiquitous due to their high specificity and affinity toward the target antigen. 52 These antibodies can be reliably generated via hybridoma technology (schematic shown in Figure 3 ) to ensure consistency and reproducibility of assay results, with minimum batch variation. The affinity constant for a typical monoclonal antibody is 10 9 L/mol which allows for nanomolar level detection of cortisol.…”